C.J. Halbrook, C.A. Lyssiotis, M. Pasca Di Magliano, A. Maitra, Pancreatic cancer: Advances and challenges, Cell 186 (2023) 1729–1754. https://doi.org/10.1016/j.cell.2023.02.014.

A.J. Grossberg, L.C. Chu, C.R. Deig, E.K. Fishman, W.L. Hwang, A. Maitra, D.L. Marks, A. Mehta, N. Nabavizadeh, D.M. Simeone, C.D. Weekes, C.R. Thomas, Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma, Ca: A Cancer Journal for Clinicians 70 (2020) 375–403. https://doi.org/10.3322/caac.21626.

Article  Google Scholar 

U. Mahmood, E. Carrier, K. Khan, Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigm, Cancer Treat. Rev. 127 (2024) 102750. https://doi.org/10.1016/j.ctrv.2024.102750.

Article  CAS  PubMed  Google Scholar 

E. Brozos-Vázquez, M. Toledano-Fonseca, N. Costa-Fraga, M.V. García-Ortiz, Á. Díaz-Lagares, A. Rodríguez-Ariza, E. Aranda, R. López-López, Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection, Cancer Treat. Rev. 125 (2024) 102719. https://doi.org/10.1016/j.ctrv.2024.102719.

Article  CAS  PubMed  Google Scholar 

Z.I. Hu, E.M. O’Reilly, Therapeutic developments in pancreatic cancer, Nat. Rev. Gastroenterol. Hepatol. 21 (2024) 7–24. https://doi.org/10.1038/s41575-023-00840-w.

Article  PubMed  Google Scholar 

M. Xu, X. Zhao, T. Wen, X. Qu, Unveiling the role of KRAS in tumor immune microenvironment, Biomed. Pharmacother. 171 (2024) 116058. https://doi.org/10.1016/j.biopha.2023.116058.

Article  CAS  PubMed  Google Scholar 

B.A. Caughey, J.H. Strickler, Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies, Drugs 84 (2024) 27–44. https://doi.org/10.1007/s40265-023-01980-8.

Article  CAS  PubMed  Google Scholar 

S.A. Long, A.M. Amparo, G. Goodhart, S.A. Ahmad, A.M. Waters, Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment, Front. Oncol. 14 (2024) 1402128. https://doi.org/10.3389/fonc.2024.1402128.

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Linehan, M. O’Reilly, R. McDermott, G.M. O’Kane, Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies, Front. Med. 11 (2024) 1369136. https://doi.org/10.3389/fmed.2024.1369136.

Article  Google Scholar 

M.D. Muzumdar, P.Y. Chen, K.J. Dorans, K.M. Chung, A. Bhutkar, E. Hong, E.M. Noll, M.R. Sprick, A. Trumpp, T. Jacks, Survival of pancreatic cancer cells lacking KRAS function, Nat. Commun. 8 (2017) 1090. https://doi.org/10.1038/s41467-017-00942-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Buscail, B. Bournet, P. Cordelier, Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer, Nature Reviews. Gastroenterology & Hepatology 17 (2020) 153–168. https://doi.org/10.1038/s41575-019-0245-4.

Article  CAS  Google Scholar 

V. Chung, J.D. Mizrahi, S. Pant, Novel Therapies for Pancreatic Cancer, Jco Oncol. Pract. (2024). https://doi.org/10.1200/OP.24.00279.

A. Desai, A.H. Xiao, D. Choi, M.D. Toruner, D. Walden, T.R. Halfdanarson, S. Alberts, R.R. McWilliams, A. Mahipal, D. Ahn, H. Babiker, G. Stybayeva, A. Revzin, S. Kizilbash, A. Adjei, T. Bekaii-Saab, A.S. Mansfield, R.M. Carr, W.W. Ma, Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma, Cancers 16 (2024) 1861. https://doi.org/10.3390/cancers16101861.

Article  CAS  PubMed  PubMed Central  Google Scholar 

E.J. Koay, Y. Lee, V. Cristini, J.S. Lowengrub, Y. Kang, F.A.S. Lucas, B.P. Hobbs, R. Ye, D. Elganainy, M. Almahariq, A.M. Amer, D. Chatterjee, H. Yan, P.C. Park, M.V. Rios Perez, D. Li, N. Garg, K.A. Reiss, S. Yu, A. Chauhan, M. Zaid, N. Nikzad, R.A. Wolff, M. Javle, G.R. Varadhachary, R.T. Shroff, P. Das, J.E. Lee, M. Ferrari, A. Maitra, C.M. Taniguchi, M.P. Kim, C.H. Crane, M.H. Katz, H. Wang, P. Bhosale, E.P. Tamm, J.B. Fleming, A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma, Clin. Cancer Res. 24 (2018) 5883–5894. https://doi.org/10.1158/1078-0432.CCR-17-3668.

Article  Google Scholar 

A. Kitao, O. Matsui, Y. Zhang, T. Ogi, S. Nakada, Y. Sato, K. Harada, N. Yoneda, K. Kozaka, D. Inoue, K. Yoshida, W. Koda, T. Yamashita, T. Yamashita, S. Kaneko, S. Kobayashi, T. Gabata, Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma, Radiology 306 (2023) e220531. https://doi.org/10.1148/radiol.220531.

Article  PubMed  Google Scholar 

J. Gao, X. Chen, X. Li, F. Miao, W. Fang, B. Li, X. Qian, X. Lin, Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics, Front. Oncol. 11 (2021) 632130. https://doi.org/10.3389/fonc.2021.632130.

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Zhou, K. Chang, H.X. Bai, B. Xiao, C. Su, W.L. Bi, P.J. Zhang, J.T. Senders, M. Vallières, V.K. Kavouridis, A. Boaro, O. Arnaout, L. Yang, R.Y. Huang, Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas, J. Neuro-Oncol. 142 (2019) 299–307. https://doi.org/10.1007/s11060-019-03096-0.

Article  CAS  Google Scholar 

M.H. Choi, S.B. Yoon, Y.J. Lee, E.S. Jung, S. Pak, D. Han, D. Nickel, Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing, Front. Oncol. 14 (2024) 1304187. https://doi.org/10.3389/fonc.2024.1304187.

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Gao, X. Chen, X. Li, F. Miao, W. Fang, B. Li, X. Qian, X. Lin, Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics, Front. Oncol. 11 (2021) 632130. https://doi.org/10.3389/fonc.2021.632130.

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Bai, L. Wu, J. Dai, K. Wang, H. Shi, Z. Lu, G. Ji, J. Yu, Q. Xu, Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients, Acad. Radiol. 30 (2023) 2954–2961. https://doi.org/10.1016/j.acra.2023.03.007.

Article  PubMed  Google Scholar 

S.H. Yoon, J.M. Lee, J.Y. Cho, K.B. Lee, J.E. Kim, S.K. Moon, S.J. Kim, J.H. Baek, S.H. Kim, S.H. Kim, J.Y. Lee, J.K. Han, B.I. Choi, Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT, Radiology 259 (2011) 442–452. https://doi.org/10.1148/radiol.11101133.

Article  PubMed  Google Scholar 

S. Lee, S.H. Kim, H.K. Park, K.T. Jang, J.A. Hwang, S. Kim, Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection, Radiology 288 (2018) 456–466. https://doi.org/10.1148/radiol.2018172331.

Article  PubMed  Google Scholar 

H. Sun, S. Zhang, K. Liu, J. Zhou, X. Wang, T. Shen, X. Song, Y. Guo, X. Wang, MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection, J. Magn. Reson. Imaging 50 (2019) 397–409. https://doi.org/10.1002/jmri.26603.

Article  PubMed  Google Scholar 

K.K. Lam, S.H. Wong, P.Y. Cheah, Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective, Cells 12 (2023). https://doi.org/10.3390/cells12040631.

S.A. Shetu, N. James, G. Rivera, D. Bandyopadhyay, Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond, Curr. Issues Mol. Biol. 45 (2023) 1914–1949. https://doi.org/10.3390/cimb45030124.

Article  CAS  Google Scholar 

Y.H. Liu, C.M. Hu, Y.S. Hsu, W.H. Lee, Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma, Cell Death Dis. 13 (2022) 817. https://doi.org/10.1038/s41419-022-05259-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z. Zhang, H. Zhang, X. Liao, H.I. Tsai, KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression, Front. Cell. Dev. Biol. 11 (2023) 1147676. https://doi.org/10.3389/fcell.2023.1147676.

Article  PubMed  PubMed Central  Google Scholar 

M.A. Attiyeh, J. Chakraborty, C.A. McIntyre, R. Kappagantula, Y. Chou, G. Askan, K. Seier, M. Gonen, O. Basturk, V.P. Balachandran, T.P. Kingham, M.I. D Angelica, J.A. Drebin, W.R. Jarnagin, P.J. Allen, C.A. Iacobuzio-Donahue, A.L. Simpson, R.K. Do, CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma, Abdom. Radiol. 44 (2019) 3148–3157. https://doi.org/10.1007/s00261-019-02112-1.

Article  Google Scholar 

L. Jia, J. Zhao, L. Zhao, J. Tian, G. Huang, Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta–analysis, Eur. J. Radiol. 158 (2023) 110640. https://doi.org/10.1016/j.ejrad.2022.110640.

Article  PubMed  Google Scholar 

M. Ronot, V. Chernyak, A. Burgoyne, J. Chang, H. Jiang, M. Bashir, K.J. Fowler, Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives, Radiology 307 (2023) e221429. https://doi.org/10.1148/RADIOL.221429.